Durin Life Sciences develops Duritect™, a blood-based test that combines autoantibody biomarkers with machine learning technology to assess patients' risk of having Alzheimer's…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Durin Life Sciences →Already a subscriber? Sign in
Xcout Intel tracks Durin Life Sciences continuously — this profile deepens as new filings, funding, people and hiring data arrive.